Back
Fulcrum Therapeutics Stock Predictions
From 50,000 investors to Nasdaq? Mode's next move...
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Buy
61
FULC
Fulcrum Therapeutics
Last Price:
$7.14
Seasonality Move:
50.31%
7 Day Trial
ALL ACCESS PASS
$
7
Big exits started like this. So did Mode
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/eliteFulcrum Therapeutics Stock Forecast
-
Over the next 52 weeks, Fulcrum Therapeutics has on average historically risen by 5.2% based on the past 5 years of stock performance.
-
Fulcrum Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
-
Is Fulcrum Therapeutics Stock Undervalued?The current Fulcrum Therapeutics [FULC] share price is $7.25. The Score for FULC is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
FULC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Fulcrum Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Fulcrum Therapeutics has on average historically risen by 5.2% based on the past 5 years of stock performance.
Fulcrum Therapeutics Stock Rating
Buy
61
Fulcrum Therapeutics (FULC)
is a Buy
Is Fulcrum Therapeutics overpriced?
-
Fulcrum Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
Fulcrum Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
fulcrumtx.com
52-Week Data
52-Week High:
10.13
52-Week Low:
2.32
Prediction Charts
Market Cap:
391.3M
Price in USD:
7.25
Volume:
388.3K
Beta:
2.43
Technical Analysis
SMA50:
4.73
SMA100:
4.17
SMA200:
4.44
52-Wk Change:
-13.38%
Stock Predictions
-
Is Fulcrum Therapeutics stock public?Yes, Fulcrum Therapeutics is a publicly traded company.
-
What is the Fulcrum Therapeutics stock quote today?The Fulcrum Therapeutics stock price is 7.25 USD today.
-
How to buy Fulcrum Therapeutics stock online?You can buy Fulcrum Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-19 | 6.75 | 6.93 | 7.04 | 6.52 |
| May-20 | 6.92 | 6.51 | 7.00 | 6.25 |
| May-21 | 6.40 | 6.25 | 6.80 | 6.23 |
| May-22 | 6.18 | 6.12 | 6.27 | 5.90 |
| May-23 | 6.82 | 6.44 | 7.04 | 6.25 |
| May-27 | 6.55 | 6.35 | 6.82 | 6.03 |
| May-28 | 6.28 | 6.90 | 7.00 | 6.23 |
| May-29 | 7.11 | 7.07 | 7.48 | 6.98 |
| May-30 | 7.02 | 6.88 | 7.08 | 6.67 |
| Jun-2 | 6.97 | 6.96 | 7.11 | 6.64 |
| Jun-3 | 6.96 | 7.04 | 7.17 | 6.82 |
| Jun-4 | 7.03 | 7.03 | 7.10 | 6.83 |
| Jun-5 | 7.03 | 7.11 | 7.40 | 6.89 |
| Jun-6 | 7.23 | 7.25 | 7.40 | 7.10 |
Fulcrum Therapeutics Earnings
Fulcrum Therapeutics Earnings Report: Per Share Fulcrum Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Fulcrum Therapeutics Forecast Revenue Growth
Fulcrum Therapeutics Stock Analysis: Historical quarterly revenues per share for Fulcrum Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, an increase next quarter of $0.43 per share, a decrease this year of $1.02 per share, and a decrease next year of $0.01 per share.
* Fulcrum Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.